Cargando…
Adalimumab for induction of remission in patients with Crohn's disease: a systematic review and meta-analysis
PURPOSE: A large number of people with Crohn's disease (CD) fail to recover from conventional therapy or biological therapy. Some studies showed that adalimumab (ADA) may be an effective alternative therapy for these patients. The aim of this study was to evaluate the efficacy and safety of ADA...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523983/ https://www.ncbi.nlm.nih.gov/pubmed/36175983 http://dx.doi.org/10.1186/s40001-022-00817-6 |